Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Mirjam, Stahl"'
Autor:
Felix Doellinger, Grzegorz Bauman, Jobst Roehmel, Mirjam Stahl, Helena Posch, Ingo G. Steffen, Orso Pusterla, Oliver Bieri, Mark O. Wielpütz, Marcus A. Mall
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundPrevious studies showed that contrast-enhanced (CE) morpho-functional magnetic resonance imaging (MRI) detects abnormalities in lung morphology and perfusion in patients with cystic fibrosis (CF). Novel matrix pencil decomposition MRI (MP-M
Externí odkaz:
https://doaj.org/article/d30e0f3e95134ae39a69e52e8fdb80d0
Autor:
Susanne J.H. Vijverberg, Asterios Kampouras, Halime Nayir Büyükşahin, Heidi Makrinioti, Laura Petrarca, Mehtap Schmidt, Leonie D. Schreck, Ruth M. Urbantat, Nicole Beydon, Myrofora Goutaki, Anna Lavizzari, Marijke Proesmans, Dirk Schramm, Mirjam Stahl, Angela Zacharasiewicz, Alexander Moeller, Marielle W. Pijnenburg
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Respiratory health in children is essential for general wellbeing and healthy development in the short and long term. It is well known that many respiratory diseases in adulthood have their origins in early life, and therefore research on prevention
Externí odkaz:
https://doaj.org/article/075dd356506c4374b14ae2fd05eabb0b
Publikováno v:
Breathe, Vol 19, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/a6a3e4e4d8dd476884d1dec49b1b123c
Autor:
Sivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, Florian Stehling, Folke Brinkmann, Manuel Burkhart, Helmut Ellemunter, Anna-Maria Dittrich, Christina Smaczny, Olaf Eickmeier, Matthias Kappler, Carsten Schwarz, Sarah Sieber, Susanne Naehrig, Lutz Naehrlich, Klaus Tenbrock, Claus Pfannenstiel, Dirk Steffen, Jochen Meister, Britta Welzenbach, Anette Scharschinger, Markus Kratz, Maike Pincus, Tobias Tenenbaum, Mirjam Stahl, Kerstin Landwehr, Stefanie Dillenhöfer, Hans Kössel, Petra Kaiser, Manfred Käding, Simone Stolz, Stefan Blaas, Jutta Hammermann, Monika Gappa, Antje Schuster, Dana Spittel, Sabine Zirlik, Sabina Schmitt, Joachim Bargon, Malte Cremer, Sebastian Fähndrich, Andrea Heinzmann, Lutz Nährlich, Stefan Kuhnert, Sebastian Schmidt, Bettina Wollschläger, Anna Nolde, Inka Held, Wolfgang Kamin, Felix C. Ringshausen, Sabine Wege, Olaf Sommerburg, Norbert Geier, Sara Lisa Fleser, Heinrike Wilkens, Michael Lorenz, Paul Vöhringer, Martin Schebek, Christian Timke, Ingrid Bobis, Thomas Nüßlein, Doris Dieninghoff, Ernst Rietschel, Bastian Klinkhammer, Freerk Prenzel, Alexandra Wald, Axel Kempa, Eva Lücke, Ines Adams, Krystyna Poplawska, Simone Lehmkühler, Monika Bauck, Anne Pfülb, Rainald Fischer, Gudrun Schopper, Susanne Nährig, Matthias Griese, Jörg Grosse, Peter Küster, Birte KinderHolger Köster, Susanne Büsing, Margarethe Pohl, Andreas Artlich, Alexander Kiefer, Manfred Ballmann, Nikola Gjorgjevski, Markus A. Rose, Friederike Ruf, Rolf Mahlberg, Wolfgang Thomas, Ute Graepler, Sebastian Bode, hilipp Meyn, Josef Rosenecker, Cordula Koerner, Klaus-Michael Keller, Tina Teßmer, Helge Hebestreit, Gerhild Lohse
Publikováno v:
The Lancet Regional Health. Europe, Vol 32, Iss , Pp 100690- (2023)
Summary: Background: Treatment with elexacaftor/tezacaftor/ivacaftor (ETI) improves multiple clinical outcomes in people with cystic fibrosis (pwCF) with at least one F508del allele. This study evaluated the real-world impact of ETI on lung function,
Externí odkaz:
https://doaj.org/article/cb7f1132ad9145b4909f1a838def4b95
Autor:
Jessica Rademacher, Luise Martin, Anja Theloe, Mirjam Stahl, Marcus A. Mall, Oana Joean, Jan Fuge, Gesine Hansen, Tobias Welte, Katharina Schütz, Felix C. Ringshausen, Anna M. Dittrich
Publikováno v:
ERJ Open Research, Vol 9, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/1db4ca9ebe8f422c99e791faf3d014c2
Autor:
Julian Berges, Simon Y. Graeber, Susanne Hämmerling, Yin Yu, Arne Krümpelmann, Mirjam Stahl, Stephanie Hirtz, Heike Scheuermann, Marcus A. Mall, Olaf Sommerburg
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Rationale: Lumacaftor/ivacaftor was approved for the treatment of patients with cystic fibrosis who are homozygous for F508del aged 2 years and older following positive results from phase three trials. However, the improvement in CFTR function associ
Externí odkaz:
https://doaj.org/article/6c73e53185be46f1bc745000132421e9
Autor:
Cristina Ardura-Garcia, Katharina Kainz, Maria Christina Mallet, Laura Petrarca, Jasna Rodman Berlot, Monique Slaats, Carmen Streibel, Susanne Vijverberg, Emma E. Williams, Myrofora Goutaki, Diane M. Gray, Anna Lavizzari, Rory E. Morty, Marijke Proesmans, Dirk Schramm, Mirjam Stahl, Angela Zacharasiewicz, Alexander Moeller, Mariëlle W. Pijnenburg
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
This review has been prepared by the Early Career Members and Chairs of the European Respiratory Society (ERS) Assembly 7: Paediatrics. We here summarise the highlights of the advances in paediatric respiratory research presented at the ERS Internati
Externí odkaz:
https://doaj.org/article/0cfa715f13344627b7fb5448dec482c5
Autor:
Linus Piehler, Ralf Thalemann, Christine Lehmann, Stephanie Thee, Jobst Röhmel, Zulfiya Syunyaeva, Mirjam Stahl, Marcus A. Mall, Simon Y. Graeber
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: The CFTR modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) was shown to improve CFTR function and clinical symptoms in patients with cystic fibrosis (CF) with at least one F508del allele. Recently, some case reports suggested potent
Externí odkaz:
https://doaj.org/article/7ae8a967ccd34950a7f3cc31a5ca7a99
Autor:
Lena Wucherpfennig, Felix Wuennemann, Monika Eichinger, Angelika Seitz, Ingo Baumann, Mirjam Stahl, Simon Y. Graeber, Shengkai Zhao, Jaehi Chung, Jens-Peter Schenk, Abdulsattar Alrajab, Hans-Ulrich Kauczor, Marcus A. Mall, Olaf Sommerburg, Mark O. Wielpütz
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Chronic rhinosinusitis (CRS) usually presents with nasal congestion, rhinorrhea and anosmia impacts quality of life in cystic fibrosis (CF). Especially mucopyoceles pathognomonic for CRS in CF may cause complications such as spread of i
Externí odkaz:
https://doaj.org/article/9457291a67fc47c8a7f559c9d492eb6d
Autor:
Carsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, Thordis Hohnstein, Christina Iwert, Claudia Grehn, Jobst Roehmel, Eva Steinke, Mirjam Stahl, Laura Lozza, Ekaterina Tikhonova, Elisa Rosati, Ulrik Stervbo, Nina Babel, Jochen G. Mainz, Hilmar Wisplinghoff, Frank Ebel, Lei-Jie Jia, Matthew G. Blango, Peter Hortschansky, Sascha Brunke, Bernhard Hube, Axel A. Brakhage, Olaf Kniemeyer, Alexander Scheffold, Petra Bacher
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 5 (2023)
BACKGROUND The fungus Aspergillus fumigatus causes a variety of clinical phenotypes in patients with cystic fibrosis (pwCF). Th cells orchestrate immune responses against fungi, but the types of A. fumigatus–specific Th cells in pwCF and their cont
Externí odkaz:
https://doaj.org/article/952a35bb46204b4d99016140937e7c30